Combining Dual Immune Checkpoint Inhibition with Radiotherapy Fails to Enhance Progression-Free Survival in Newly Diagnosed MGMT-Unmethylated Glioblastoma Patients
In a striking development in neuro-oncology, the recent outcomes of the National Cancer Institute (NCI)-sponsored phase II/III trial NRG-BN007 have cast doubt on the promise...